A trial to assess a new therapy for artery weakening

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Approximately 5% of men and 1% of women aged over 60 years develop weakening of the main abdominal artery. Currently the management of artery weakening is focused on surgery with no effective medications available. In this trial we will examine the value of a promising drug therapy. If proved effective this medication could reduce the requirement for surgery by controlling artery weakening at an early stage in its development.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $1,105,894.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

abdominal aortic aneurysm | angiotensin II | biomarkers | cardiovascular disease prevention | clinical trial | treatment strategies | vascular surgery